COVID-19 vaccination and cancer immunotherapy: should they stick together?

The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is...

Descripción completa

Detalles Bibliográficos
Autores principales: Brest, Patrick, Mograbi, Baharia, Hofman, Paul, Milano, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603902/
https://www.ncbi.nlm.nih.gov/pubmed/34799696
http://dx.doi.org/10.1038/s41416-021-01618-0
_version_ 1784601854087266304
author Brest, Patrick
Mograbi, Baharia
Hofman, Paul
Milano, Gerard
author_facet Brest, Patrick
Mograbi, Baharia
Hofman, Paul
Milano, Gerard
author_sort Brest, Patrick
collection PubMed
description The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments.
format Online
Article
Text
id pubmed-8603902
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86039022021-11-22 COVID-19 vaccination and cancer immunotherapy: should they stick together? Brest, Patrick Mograbi, Baharia Hofman, Paul Milano, Gerard Br J Cancer Comment The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments. Nature Publishing Group UK 2021-11-19 2022-01-01 /pmc/articles/PMC8603902/ /pubmed/34799696 http://dx.doi.org/10.1038/s41416-021-01618-0 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021
spellingShingle Comment
Brest, Patrick
Mograbi, Baharia
Hofman, Paul
Milano, Gerard
COVID-19 vaccination and cancer immunotherapy: should they stick together?
title COVID-19 vaccination and cancer immunotherapy: should they stick together?
title_full COVID-19 vaccination and cancer immunotherapy: should they stick together?
title_fullStr COVID-19 vaccination and cancer immunotherapy: should they stick together?
title_full_unstemmed COVID-19 vaccination and cancer immunotherapy: should they stick together?
title_short COVID-19 vaccination and cancer immunotherapy: should they stick together?
title_sort covid-19 vaccination and cancer immunotherapy: should they stick together?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603902/
https://www.ncbi.nlm.nih.gov/pubmed/34799696
http://dx.doi.org/10.1038/s41416-021-01618-0
work_keys_str_mv AT brestpatrick covid19vaccinationandcancerimmunotherapyshouldtheysticktogether
AT mograbibaharia covid19vaccinationandcancerimmunotherapyshouldtheysticktogether
AT hofmanpaul covid19vaccinationandcancerimmunotherapyshouldtheysticktogether
AT milanogerard covid19vaccinationandcancerimmunotherapyshouldtheysticktogether

Ejemplares similares